Keyword Connections

posaconazole

Journals

10

1 Dalton transactions (Cambridge, England : 2003)

2 Journal of pharmaceutical and biomedical analysis

3 the british journal of dermatology

4 the journal of physical chemistry a

5 emerging microbes & infections

6 The American journal of tropical medicine and hygiene

7 biological & pharmaceutical bulletin

8 the journal of heart and lung transplantation : the official publication of the international society for heart transplantation

9 Antiviral research

10 Current oncology reports

Research Groups

0

No Research Group Connected

Bibliographies

19

1 The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo.

2 Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein.

3 Prophylactic Measures During Induction for Acute Myeloid Leukemia.

4 Disseminated Autochthonous Dermal Leishmaniasis Caused by (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

5 successful treatment of pulmonary mucormycosis in a child with aplastic anemia

6 heat shock protein 90 and calcineurin pathway inhibitors enhance the efficacy of triazoles against scedosporium prolificans via induction of apoptosis

7 Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism.

8 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

9 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

10 Role of posaconazole in the treatment of oropharyngeal candidiasis

11 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

12 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

13 Role of posaconazole in the treatment of oropharyngeal candidiasis

14 Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

15 Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.

16 Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae).

17 Separation of twelve posaconazole related stereoisomers by multiple heart-cutting chiral-chiral two-dimensional liquid chromatography.

18 comparison of clinical pharmacology of voriconazole and posaconazole

19 economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in canada